Delivery Order V797D30107-36E79721N0043
Award Date
7/7/21
Potential Completion Date
1/31/22
Potential Value
$116K
Federal Agency
National Acquisition Center
Awardee
Mylan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morgantown, WV 26505, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Department of Veterans Affairs National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The order, valued at $220,152.24, is for the supply of the drug spironolactone in support of the VA Pharmaceutical Prime Vendor program. Spironolactone is a cardiovascular medication that will be distributed to VA medical facilities for use in veteran patient care. Mylan has previously held other prime contracts...
The Department of Veterans Affairs National Acquisition Center awarded a delivery order to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, for the supply of spironolactone in support of the VA Pharmaceutical Prime Vendor program. This $192,860.64 firm fixed price delivery order facilitated the distribution of this critical cardiovascular medication to VA medical facilities for use in veteran patient care. Mylan has previously provided other specialty drug...
This is a delivery order awarded by the Department of Veterans Affairs National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit pharmaceutical manufacturer, for the supply of spironolactone in support of the VA's Pharm Prepackaging Program. The $161,930.16 firm fixed price contract has an October 30, 2020 completion date and was issued on September 15, 2020. No set-aside designation was used. Mylan has a track record of providing critical medications such as clozapine, alprazolam,...
This is a delivery order awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Mylan Pharmaceuticals Inc. for the supply of spironolactone, a drug used in the VA's Pharmaceutical Pre-Packaging Program. The $76,416.48 fixed-price delivery order was issued under Mylan's existing Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs. The contract has a completion date of June 30, 2020 and does not have a set-aside designation. Mylan is a for-profit...
This federal contract award is a delivery order for spironolactone tablets issued by the Department of Veterans Affairs National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The order is placed under a Blanket Purchase Agreement (BPA) call, which is part of the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The order has a potential value of $124,977.60 and a completion date of January 31, 2018. The contract...
This is a firm fixed-price task order issued by the U.S. Department of Veterans Affairs National Acquisition Center to Mylan Pharmaceuticals Inc. to purchase bulk spironolactone tablets for the VA Pharmaceutical Repackaging Program. The task order has a ceiling value of $84,265.20 and a performance period ending on March 31, 2019. It was awarded on February 6, 2019 under the Pharmaceuticals and Drugs Federal Supply Schedule contract. Mylan Pharmaceuticals is a for-profit manufacturer of...
The U.S. Defense Logistics Agency (DLA) awarded a $4,788.96 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,353,066 units of 50 mg Spironolactone tablets. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs. The contract does not have a set-aside...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPP04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,971.15 firm fixed price delivery order is for the supply of 4,563,865,448 units of Spironolactone 50 mg tablets, a medication commonly used to treat various medical conditions. The contract has an ultimate completion date of March 6, 2024 and was awarded on March 5, 2024. Amerisourcebergen Drug Corp is a major...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,623,879 units of Spironolactone 50 mg tablets. The contract has a Firm Fixed Price of $3,864.12 and an ultimate completion date of January 18, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and is registered in the System for Award Management (SAM.gov) as a for-profit organization. The contract is not designated...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,478,971 units of 100mg Spironolactone tablets over a term ending on March 7, 2025. The $2,031.08 Firm Fixed Price contract was awarded on March 6, 2025 by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...